McMullin David (CIK 0001738662)

Latest company ownership

Role: Chief Commerical Officer
Shares held
250,000
Last filed at
Mar 6, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 5, 2019 Sep 9, 2019 Aldeyra Therapeutics, Inc. Chief Commerical Officer Buy 91.3 +4,329 237.99% $20.3K